Cargando…
SUN-255 The Synthetic Progestin, 17-alpha-hydroxyprogesterone Caproate, Used in Human Pregnancy Alters Prefrontal Cortical Development in Rats
17-alpha-hydroxyprogesterone caproate (17-OHPC) is a synthetic progestin commonly prescribed for the prevention of recurrent preterm birth. Treatment with 17-OHPC in high-risk pregnant women begins between gestational weeks 16-20, and continues through week 36 (1). Recent studies suggest that 17-OHP...
Autores principales: | Lolier, Melanie L, Wagner, Christine K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207340/ http://dx.doi.org/10.1210/jendso/bvaa046.1761 |
Ejemplares similares
-
SAT-255 Pituitary Adenoma With TSH and GH Co Secretion
por: Riquelme, Romina, et al.
Publicado: (2020) -
Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro
por: Sexton, Donal J, et al.
Publicado: (2004) -
MON-255 Oral Contraceptive Pills Mask an Aggressive Crooke’s Cell Pituitary Adenoma
por: Gnanapragasam, Helen Prathiba, et al.
Publicado: (2020) -
The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use
por: Ransom, Carla E., et al.
Publicado: (2011) -
Maternal Characteristics Influencing the Development of Gestational Diabetes in Obese Women Receiving 17-alpha-Hydroxyprogesterone Caproate
por: Egerman, Robert, et al.
Publicado: (2014)